Seema S. Singh

FDA investigator

Appears on 6 documents from 2015 to 2020, mostly at sites in California. Most often cites design controls (21 CFR 820.30).

6
Documents on file
3.0
Observations per 483
2015
First seen
2020
Most recent

What they cite most

From 18 observations

Activity by year

2015: 3, 2016: 1, 2017: 1, 2020: 1

Where

California 5 · India 1

Is Seema S. Singh coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 AUROLAB TRUST DBA AurolabFeb 6, 2020 · Madurai, India
483 Haemonetics Software SolutionsMar 21, 2017 · El Dorado Hills, California
483 Proteus Digital HealthMar 11, 2016 · Hayward, California
483 Theranos, Inc.Sep 16, 2015 · Palo Alto, California
483 Somersault Orthopedics, IncFeb 26, 2015 · Pleasanton, California
483 Bentec Medical, IncJan 29, 2015 · Woodland, California

About this profile

What does Seema S. Singh inspect?

Seema S. Singh appears on 6 documents on file covering 6 sites, mostly in California.

What do they cite most often?

21 CFR 820.30 (design controls), followed by 21 CFR 820.75(a) and 21 CFR 820.100(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Seema S. Singh is dated Feb 6, 2020.